Focus: Structure Therapeutics is a public biotech company focused on oral small molecule drugs that deliver biologic-like activity and specificity, targeting metabolic and infectious diseases. The company is in clinical-stage development with a lean operational footprint of 28 active job openings.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Hot — 211 jobs added in 30d
Net +193 (211 new, 18 removed). Aggressive expansion phase.
Suited for scientists and clinicians willing to accept early-stage risk for potential platform upside; not ideal for those seeking stability or established product teams.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Structure Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Structure Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles